# Trade Mark Journal No.2025/043 24 October 2025

## UK00004241077 29 July 2025 (36,42)

TEZ BIO

Class 36
  Providing private equity and investment funding; venture capital services relating to providing financing to emerging companies, start-up companies, small businesses, developing companies, and late-stage companies and entrepreneurs; venture capital funding services to emerging companies, start-up companies, small businesses, developing companies, and late-stage companies and entrepreneurs; venture capital funding services to pharmaceutical companies, biotechnology companies, vaccine companies, chemical companies, medical devices companies, diagnostic companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), clinical research companies, software companies, and hardware companies; providing working capital financing to businesses and business owners, including emerging and start-up companies; providing working capital financing to pharmaceutical companies, biotechnology companies, vaccine companies, chemical companies, medical devices companies, diagnostic companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), clinical research companies, software companies, and hardware companies; providing venture capital, development capital, private equity and investment funding to emerging companies, start-up companies, small businesses, developing companies, and late-stage companies and entrepreneurs; providing venture capital, development capital, private equity and investment funding to pharmaceutical companies, biotechnology companies, vaccine companies, chemical companies, medical devices companies, diagnostic companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), clinical research companies, software companies, and hardware companies; providing funding for joint ventures; providing funding for inventions; providing funding for research, development, and commercialization of products and services in the field of biological research, medical research, chemical research, pharmaceuticals, nutraceuticals, reagents, chemicals, enzymes, medical devices, biopharmaceuticals, vaccines, biologics, biotherapeutics, and biosimilars; providing project grants for research, development, and commercialization of products and services in the field of biological research, medical research, chemical research, pharmaceuticals, nutraceuticals, reagents, chemicals, enzymes, medical devices, biopharmaceuticals, vaccines, biologics, biotherapeutics, and biosimilars; equity capital investment; financing of business ventures; creation and management of venture capital investment funds that invest in emerging companies, start-up companies, small businesses, developing companies, and late-stage companies, and entrepreneurs; creation and management of venture capital investment funds that invest in pharmaceutical companies, biotechnology companies, vaccine companies, chemical companies, medical devices companies, diagnostic companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), clinical research companies, software companies, and hardware companies.
Class 42
  Biological research; medical research; scientific laboratory services; scientific research; chemical research; research and development of new products for others; technological research; scientific, medical, biological research and development in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, biosimilars; clinical trials and testing services in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, biosimilars; engineering services relating to research and development of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; Software as a service (SaaS); creation of websites for others featuring information in the pharmaceutical, medical and health fields; hosting of a website featuring information in the pharmaceutical, medical and health fields; hosting podcasts; Software as a service (SaaS) services featuring computer software for designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of structure, function, sequence, dynamics, stability, and thermodynamics of nucleic acids, polynucleotides, oligonucleotides, proteins, antigens, immunogens, antibodies, nanobodies, drug conjugates, ligands, peptides, amino acids, nucleotides, nucleosides, carbohydrates, adjuvants, drug delivery carriers, lipids, polymers, and formulations; Software as a service (SaaS) services featuring computer software for use in designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of experiments related to molecular biology, cell biology, biochemistry, organic chemistry, inorganic chemistry, biophysics, immunology, sequencing, toxicology, pharmacodynamics, pharmacokinetics, biodistribution, formulation, drug delivery, bioassays, analytical assays, and analytical characterization for production or manufacturing of pharmaceutical and biopharmaceutical preparations, data management, or clinical trial management.

POPVAX PRIVATE LIMITED

Representative: Dennemeyer & Company Limited